Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy; the iFOCUS Study

NCT06524570 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT06524570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy; the iFOCUS Study
Lead sponsor
UMC Utrecht
Phase
Phase 1
Overall status
Recruiting
Start date
July 26, 2024
Completion date
August 1, 2030
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastatic cancer